Stanford University Researchers Report that Ciprofloxacin Use Drives Persistent Antibiotic Resistance in Human Gut Bacteria, with Resistance Independently CROSTANCE IndEPENDENCE For over 10 weeks.

Antimicrobial resistance (Amr) is a global health concerted to millions of deaths Each year. It is widely driven by excessive and inappropriate antibiotic use. Past Efforts to study amr have trouble revised on in vitro experiences and animal models, which fall short in replicating the full complexity of Human Microbial Environments.

In the study Titled “Brief Antibiotic Use Drives Human Gut Bacteria Towards Low-Cost Resistance,” Published in Nature.

Sixty Healthy Adults Received Ciprofloxacin, 500 Mg Twice Daily, For Five Days. Over a 20-wheek period, participants collected 16 stool samples, yielding 960 samples for analysis. Shotgun metagenomic sequencing was performed on all Samples, Generating an average of 18.8 million reads per sample. A computational tool named polypanner was developed to identify true polymorphic sites across time.

Researchers Reconstructed 5,665 genomes representing commensal bacterial populations and identified 2.3 Million gentic variants. Among these, 513 populations exhibited selective sweeps, clear evidence of adaptive evolution. A high concentration of mutations occurred in gyra, a gene associated with fluoroquinolone resistance.

Among the 513 evolving populations, sweping genetic changes frequently Occurred in Gyra, a Gene Central to Fluoroquinolone Resistance. SIXTY-Three Populations Across 34 Participants Exhibited Gyra Mutations, which typically Arose independently within individuals. Nearly 10% of initially susceptible bacterial populations Acquired Resistance Through these Mutations.

Once Establed, Gyra Sweeps Persified Beyond 10 Weeks and WeE Predicted to Remain Detectable for up to a year. Additional resistance -associated mutations occurred in other genes, thought these events were less common and appeared in more special.

Resistance was more likely to emerge in populations that was Abundant Before Treatment and Experienced Significant Declines Dining Exposure, Identation Correlated with Higher Odds of Evolvertionary Change.

Resistance Mutations did not come with fitness costs, allowing resistant strains to retain a dominant population after treatment. Targeted Sequencing Showed No Evidence of Resistance Reversion. Mutations in Gyra Accounted for only part of the observed resistance, suggesting additional mechanisms.

Based on the results, even short-term antibiotic use can lead to resistance mutations that person in the human gut for months after treatment ends. Mutations Arise Independently Across Bacterial Species and Do Not Incur a Measurable Fitness Cost, Allowing Resistant Strains to Remain Prevalent.

Gut Microbes Proved Capable of Evolving Resistance with Prior Infection. Commensal Populations May TheRefore Act as Reservoirs for Resistance Traits that Cold Transfer to Pathogenic Bacteria Through Horizontal Genersfer Beyond the intuition with annex.

Because Resistance Evolved Predictibly Based on Population Size, It Allows for the Possibility of Predicting Resistance Resistance Outomes If the Starting Population is Known of Treatment of Treatment. Experiences with Differing Admixes of Starting Population and Treatment Types are needed to full expand this predictive modeling.

Monitoring Microbial Composition and Abundance Before and during Treatment Cold Help Guide More Precise Antibiotic Use, Reduce long-term reliefs associateed with resistance and Improve Overall State founder of antibiotic use.

© 2025 Science X Network